This Pitch Perfect contest track reflected technology to remove financial barriers for their patients, automating workflows, reducing inefficiency and waste associated with the Prior Authorization process, and more.
Time is running out to register for INVEST Digital Health virtual conference, scheduled for September 21-25. In addition to compelling panel discussions, it will spotlight startups who will present their products and services to teams of judges in four categories.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Executives with Kaiser Permanente, Houston Methodist, Providence St. Joseph Health and Highmark Health shared their thoughts on the future of digital health and how they used technology to care for their patients at the start of the Covid-19 pandemic.
Highmark Health is reimbursing Moving Analytics' virtual cardiac rehab tool through an innovation program and is expected to roll it out more broadly should the tool lower readmissions and lower costs.
Highmark Health is turning its internal VITAL Innovation program into a commercial offering meant to help startups test their products in real-world clinical environments.
Also, Philips has acquired Northern Ireland-based digital pathology firm PathXL and Impax has agreed to purchase generic drugs from Teva and Allergan in a $568 million deal that the FTC required in order for Teva's $40 billion acquisition of Allergan to move forward.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Also, Highmark Health is suing the federal government to get what it says is owed for the risk corridor provision of the Affordable Care Act and assaults at New Jersey's largest hospital hit 300 last year.